Nanoparticle-mediated reprogramming of circulating monocytes and neutrophils to decrease inflammation-mediated damage after trauma
纳米颗粒介导的循环单核细胞和中性粒细胞重编程可减少创伤后炎症介导的损伤
基本信息
- 批准号:9978712
- 负责人:
- 金额:$ 69.69万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2019
- 资助国家:美国
- 起止时间:2019-07-16 至 2024-06-30
- 项目状态:已结题
- 来源:
- 关键词:AcuteAnti-Inflammatory AgentsBenefits and RisksBindingBiodistributionBloodBlood CirculationCardiacCell CommunicationCell DeathCellsChargeDataDevelopmentEnvironmentGoalsImmuneImmune responseIndividualInfarctionInflammationInflammatoryInflammatory ResponseInjectionsInjuryIntravenousLeadMediatingMethodsMethylprednisoloneModelingMyocardialNatural regenerationNeuraxisNitric OxideOrganOutcomePharmacologic SubstancePharmacologyPhenotypePlayProductionPropertyReactive Oxygen SpeciesRecoveryRecovery of FunctionReperfusion InjuryResearchSiteSpinal CordSpinal cord injurySpleenTestingTherapeuticTimeTissuesTraumaTraumatic Brain InjuryTraumatic injuryTravelWorkaxon growthbaseconditioningcytokinedesignfunctional outcomeshealingimmunoregulationimprovedminimally invasivemonocytemyelinationnanoparticlenanoparticle deliveryneutrophilparticleperipheral bloodregenerativeresponserisk benefit ratioscavenger receptortissue degenerationtissue regenerationtrafficking
项目摘要
Summary: Regeneration of tissues following injury can be limited due to the development of strong inflammatory
responses that can lead to substantial cell death and inappropriate conditioning of the local environment, which
becomes deficient in stimulatory factors and has an excess of inhibitory factors. Our long-term goal is to develop
nanoparticles that reprogram the phenotype of monocytes and neutrophils in the blood after trauma, resulting in
altered trafficking and anti-inflammatory phenotypes that reduce the extent of damage and may support an
environment that leads to enhanced regeneration. The premise of the proposed research is based on our
preliminary data indicating the ability to deliver nanoparticles in a minimally invasive manner that target
inflammatory monocytes and neutrophils in the blood to reprogram their function, which leads to substantial
functional recovery in a spinal cord model. The particles may enhance recovery by multiple mechanisms,
including reducing immune cell accumulation at the injury, modulating the splenic microenvironment that is
known to coordinate inflammatory responses, or directly inducing an anti-inflammatory or pro-regenerative
environment at the injury. The following aims employ nanoparticles with differential binding to monocytes and
neutrophils, which influences their phenotype such as trafficking and cytokine production. Importantly, the
reprogramming is mediated solely by the physicochemical properties of the nanoparticles (e.g., size, charge,
composition) and does not involve an active pharmaceutical ingredient (API), which have been discontinued
from many applications due to the risk-benefit ratio. The focus herein is to identify the mechanism by which the
particles are enhancing functional recovery, which may also identify design parameters that are more efficient.
Aim 1 will investigate nanoparticle association with innate immune cells in circulation, and their subsequent
trafficking and phenotype in the inflammatory response. Nanoparticle injection following SCI has led to
substantial recovery gains we aim to identify the mechanisms by which the particles are promoting recovery.
Particles that induce differential binding, phenotypic polarization, and trafficking of monocytes and neutrophils
will be investigated. Aim 2 will investigate the impact of the reprogrammed immune cells on the microenvironment
within the spleen and spinal cord. Stromal and immune cells are initially investigated throughout recovery, and
we subsequently investigate the extent of axon growth, myelination, and functional recovery. Collectively, these
studies will determine the relationship between nanoparticle properties, immune modulation, and the capacity of
the environment to reduce damage and enhance functional recovery. We propose that the particles that
reprogram based on their physicochemical properties have the potential to be a transformational therapy for
trauma by providing a readily available, non-invasive means to reprogram inflammatory monocytes and
neutrophils in order to limit damage and enhance regeneration.
摘要:由于严重炎症的发展,损伤后组织的再生可能受到限制。
可能导致大量细胞死亡和当地环境不适当调节的反应,这
缺乏刺激因子,抑制因子过多。我们的长远目标是发展
纳米颗粒在创伤后重新编程血液中单核细胞和中性粒细胞的表型,导致
改变贩运和抗炎表型,减少损害程度,并可能支持
能够促进再生的环境。拟议研究的前提是基于我们的
初步数据表明,能够以微创的方式输送纳米颗粒
血液中的炎性单核细胞和中性粒细胞重新编程它们的功能,这导致大量
脊髓模型中的功能恢复。颗粒可通过多种机制提高回收率,
包括减少损伤时免疫细胞的聚集,调节脾微环境,即
已知协调炎症反应,或直接诱导抗炎或促再生
受伤时的环境。以下目标使用与单核细胞具有不同结合的纳米颗粒和
中性粒细胞,这会影响其表型,如运输和细胞因子的产生。重要的是,
重新编程仅由纳米颗粒的物理化学性质(例如,大小,电荷,
成分),且不涉及已停产的活性药物成分(原料药
由于风险-收益比的缘故,许多应用中都存在这种风险。这里的重点是确定通过什么机制
颗粒正在增强功能恢复,这也可能确定更有效的设计参数。
目标1将研究纳米颗粒与循环中的天然免疫细胞的关联,以及它们随后
炎症反应中的运输和表型。脊髓损伤后注射纳米颗粒导致
我们的目标是确定这些颗粒促进复苏的机制。
诱导单核细胞和中性粒细胞的不同结合、表型极化和运输的颗粒
将会被调查。目标2将研究重新编程的免疫细胞对微环境的影响
在脾和脊髓内。在整个康复过程中,最初会对基质和免疫细胞进行研究,
我们随后调查了轴突生长、髓鞘形成和功能恢复的程度。总而言之,这些
研究将确定纳米颗粒特性、免疫调节和免疫调节能力之间的关系
减少对环境的破坏,增强功能恢复。我们认为,这些粒子
基于它们的物理化学性质的重新编程可能成为一种变革性的治疗方法
通过提供一种容易获得的、非侵入性的手段来重新编程炎性单核细胞和
中性粒细胞,以限制损害和促进再生。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Aileen J Anderson其他文献
Aileen J Anderson的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Aileen J Anderson', 18)}}的其他基金
Investigating the role of CD44 and immune-neuro signaling mechanisms in neural stem cell responses after spinal cord injury
研究 CD44 和免疫神经信号传导机制在脊髓损伤后神经干细胞反应中的作用
- 批准号:
10467915 - 财政年份:2022
- 资助金额:
$ 69.69万 - 项目类别:
Investigating the role of CD44 and immune-neuro signaling mechanisms in neural stem cell responses after spinal cord injury
研究 CD44 和免疫神经信号传导机制在脊髓损伤后神经干细胞反应中的作用
- 批准号:
10650327 - 财政年份:2022
- 资助金额:
$ 69.69万 - 项目类别:
Multi-channeled Bridges for Promoting Chronic Spinal Cord Repair
促进慢性脊髓修复的多通道桥
- 批准号:
10249977 - 财政年份:2020
- 资助金额:
$ 69.69万 - 项目类别:
Multi-channeled Bridges for Promoting Chronic Spinal Cord Repair
促进慢性脊髓修复的多通道桥
- 批准号:
10469553 - 财政年份:2020
- 资助金额:
$ 69.69万 - 项目类别:
Multi-channeled Bridges for Promoting Chronic Spinal Cord Repair
促进慢性脊髓修复的多通道桥
- 批准号:
10700124 - 财政年份:2020
- 资助金额:
$ 69.69万 - 项目类别:
Nanoparticle-mediated reprogramming of circulating monocytes and neutrophils to decrease inflammation-mediated damage after trauma
纳米颗粒介导的循环单核细胞和中性粒细胞重编程可减少创伤后炎症介导的损伤
- 批准号:
10212226 - 财政年份:2019
- 资助金额:
$ 69.69万 - 项目类别:
Nanoparticle-mediated reprogramming of circulating monocytes and neutrophils to decrease inflammation-mediated damage after trauma
纳米颗粒介导的循环单核细胞和中性粒细胞重编程可减少创伤后炎症介导的损伤
- 批准号:
10437650 - 财政年份:2019
- 资助金额:
$ 69.69万 - 项目类别:
Nanoparticle-mediated reprogramming of circulating monocytes and neutrophils to decrease inflammation-mediated damage after trauma
纳米颗粒介导的循环单核细胞和中性粒细胞重编程可减少创伤后炎症介导的损伤
- 批准号:
10669080 - 财政年份:2019
- 资助金额:
$ 69.69万 - 项目类别:
Human neural stem cell therapy for the treatment of cervical spinal cord injury (
人类神经干细胞疗法治疗颈脊髓损伤(
- 批准号:
8503499 - 财政年份:2013
- 资助金额:
$ 69.69万 - 项目类别:
Human neural stem cell therapy for the treatment of cervical spinal cord injury (
人类神经干细胞疗法治疗颈脊髓损伤(
- 批准号:
8727119 - 财政年份:2013
- 资助金额:
$ 69.69万 - 项目类别:
相似海外基金
Development of small molecule inhibitors as anti-inflammatory agents and antidotes for arsenicals
开发作为抗炎剂和砷解毒剂的小分子抑制剂
- 批准号:
10727507 - 财政年份:2023
- 资助金额:
$ 69.69万 - 项目类别:
Discovery of New Anti-Inflammatory Agents to Treat COPD
发现治疗慢性阻塞性肺病的新型抗炎药
- 批准号:
9194162 - 财政年份:2016
- 资助金额:
$ 69.69万 - 项目类别:
Synthesis of anti-inflammatory agents and their structure-activity relationships studies
抗炎药的合成及其构效关系研究
- 批准号:
496858-2016 - 财政年份:2016
- 资助金额:
$ 69.69万 - 项目类别:
University Undergraduate Student Research Awards
NAAA Inhibitors as Anti-inflammatory Agents, Phase II
NAAA 抑制剂作为抗炎剂,II 期
- 批准号:
9201955 - 财政年份:2015
- 资助金额:
$ 69.69万 - 项目类别:
Novel flavonoids as anti-inflammatory agents in alcoholism
新型黄酮类化合物作为酒精中毒的抗炎剂
- 批准号:
8251289 - 财政年份:2014
- 资助金额:
$ 69.69万 - 项目类别:
TLR-7 Agonists as Targeted Anti-inflammatory Agents in Arthritis
TLR-7 激动剂作为关节炎的靶向抗炎药
- 批准号:
8302750 - 财政年份:2012
- 资助金额:
$ 69.69万 - 项目类别:
Design and in vivo delivery of novel anti-inflammatory agents
新型抗炎剂的设计和体内递送
- 批准号:
267940 - 财政年份:2012
- 资助金额:
$ 69.69万 - 项目类别:
Operating Grants
Development of inlammasome inhibitors to be used as anti-inflammatory agents
开发用作抗炎剂的inlammasome抑制剂
- 批准号:
8403458 - 财政年份:2012
- 资助金额:
$ 69.69万 - 项目类别:
TLR-7 Agonists as Targeted Anti-inflammatory Agents in Arthritis
TLR-7 激动剂作为关节炎的靶向抗炎药
- 批准号:
8472443 - 财政年份:2012
- 资助金额:
$ 69.69万 - 项目类别:
Development of inlammasome inhibitors to be used as anti-inflammatory agents
开发用作抗炎剂的inlammasome抑制剂
- 批准号:
8549297 - 财政年份:2012
- 资助金额:
$ 69.69万 - 项目类别: